Kidney Research and Clinical Practice

Medium cut-off dialyzer improves reduction ratios of large middle molecules associated with vascular calcification: Hyo Jin Kim, Eun Young Seong, Sang Heon Song; Received March 15, 2023 Accepted July 31, 2023 Published online January 25, 2024; [Epub ahead of print]; Full text PubReader ePub PDF Supplementary Material

Comparison of the medium cutoff dialyzer and postdilution hemodiafiltration on the removal of small and middle molecule uremic toxins: Chang Seong Kim, Soo Yeon Joo, Hong Sang Choi, Eun Hui Bae, Seong Kwon Ma, Soo Wan Kim; Kidney Res Clin Pract. 2023;42(6):712-722. Published online June 15, 2023; DOI: https://doi.org/10.23876/j.krcp.21.287
Web of Science 1 Cited By 1; Full text PubReader ePub PDF Supplementary Material

Sustained uremic toxin control improves renal and cardiovascular outcomes in patients with advanced renal dysfunction: post-hoc analysis of the Kremezin Study against renal disease progression in Korea: Ran-hui Cha, Shin Wook Kang, Cheol Whee Park et al.; Kidney Res Clin Pract. 2017;36(1):68-78. Published online March 31, 2017; DOI: https://doi.org/10.23876/j.krcp.2017.36.1.68
Web of Science 33 Cited By 31; Full text PubReader PDF Supplementary Material

14,672	Validation of operational definitions of mortality in a nationwide hemodialysis population using the Health Insurance Review and Assessment Service databases of Korea
19,680	C4d Puzzle in ABO-incompatible kidney transplantation
8,022	How should we treat acute kidney injury caused by renal congestion?
12,825	Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options
34,892	Uremic pruritus: pathophysiology, clinical presentation, and treatments

Cited By 14	Association between blood pressure and the risk of chronic kidney disease in treatment-naïve hypertensive patients
Cited By 13	Exploring molecular targets in diabetic kidney disease
Cited By 13	Application of C5 inhibitors in glomerular diseases in 2021
Cited By 13	GLP-1 receptor agonists in diabetic kidney disease: current evidence and future directions
Cited By 11	Prostaglandin E2 receptors as therapeutic targets in renal fibrosis

Search